Peter Neupert, Lead Independent Director at Adaptive Biotechnologies Corp.. Biography, career history and compensation sourced from SEC proxy filings.
About
Peter Neupert has served on Adaptive Biotechnologies' board of directors since December 2013, is the Lead Independent Director and chairs the Nominating and Corporate Governance Committee. He was an Operating Partner at Health Evolution Partners (2012-2014), Corporate Vice President of the Health Solutions Group at Microsoft (2005-2012) and Chief Executive Officer and Chairman of Drugstore.com, which he joined in 1998. He currently serves on the boards of Laboratory Corporation of America Holdings and Fortrea Holdings Inc., where he served as acting Chief Executive Officer from May 2025 to August 2025 and is chair of the board. Mr. Neupert holds an MBA from the Tuck School of Business at Dartmouth College and a BA in Philosophy from Colorado College.
Roles
Adaptive Biotechnologies Corp.
Lead Independent Director · Current role
December 2013–present
Health Evolution Partners
Operating Partner
February 2012 - July 2014
Microsoft
Corporate Vice President, Health Solutions Group
August 2005 - January 2012
Drugstore.com
Chief Executive Officer and Chairman
July 1998 - 2005
External Roles
Laboratory Corporation of America Holdings
Director
—
Fortrea Holdings Inc.
Chair of the Board
2025 - present
Fred Hutchinson Cancer Research Center
Trustee
2007 - 2020
Director Compensation
FY 2025
Fees earned or paid in cash
$105,000
Component$60,000 annual cash retainer plus any lead-director/committee-chair fees earned in FY2025
Option awards
$124,998
ComponentAnnual stock option grant, ASC 718 grant-date fair value
Stock awards
$124,999
ComponentAnnual RSU grant, ASC 718 grant-date fair value